In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to:

• Engage key stakeholders in the provision of HBV care​
• Provide HBV management resources to support PCPs who are doing screening​
• Consider specialty and primary care collaborations that empower PCPs with clear guidance on how to manage patients living with HBV

Presenters:

Su Wang, MD, MPH, FACP
Medical Director
Center for Asian Health and Viral Hepatitis Programs
Cooperman Barnabas Medical Center
RWJBarnabas-Rutgers Medical Group
Associate Member
Health Care Policy and Aging Research
The Rutgers Institute for Health
Senior Advisor
Global Health, Hepatitis B Foundation
Florham Park, New Jersey

Richard R. Andrews, MD, MPH
President, Houston Viral Hepatitis Task Force
Former Co-Chair, National Task Force on Hepatitis B
Board-Certified Family Medicine
Addiction Medicine Physician
Houston, Texas

Ruth Brogden, MPH
Patient Advocate

Amy S. Tang, MD
Former Co-Chair, National Task Force on Hepatitis B
Director of Immigrant Health
North East Medical Services
San Francisco, California

Link to full program: 
https://bit.ly/3TuqFHI

Link to the slides:
https://bit.ly/44hXpHu

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include:

• Patient subgroups to consider for treatment outside guideline criteria
• Adverse event and cost-effectiveness considerations
• Integration of patient perspectives in wider treatment

Presenters:

Mark S. Sulkowski, MD, FIDSA, FAASLD
Professor of Medicine
Director, Division of Infectious Diseases, Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Tatyana Kushner, MD, MSCE
Associate Professor
Division of Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New York

Paul Y. Kwo, MD
Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Jacki Chen, PhD
Patient Advocate 

Link to full program: 
https://bit.ly/3TuqFHI

Link to the slides:
https://bit.ly/4a60GM4

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP, and Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, discuss the use of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes, including:

• Overview of chronic kidney disease
• Guideline recommendations
• Evidence for finerenone
• Role of the pharmacist

Presenter:

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP
Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator
Endocrinology and Metabolism Institute
Cleveland Clinic
Cleveland, Ohio

Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP
Vice Chair and Allen I. White Distinguished Professor
Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences  
Washington State University
Spokane, Washington

Review the downloadable slideset and the full program at:
https://bit.ly/3wxNAod

This podcast is the third in a series of three featuring insights from expert cardiology pharmacists on nonvalvular atrial fibrillation (NVAF). In this episode, pharmacist Kathleen A. Lusk, PharmD, BCPS, BCCP, provides an overview of health disparities, patient engagement, and collaborative team-based care to optimize outcomes for patients with NVAF. Dr Lusk reviews best practices in using the principles of motivational interviewing to employ shared decision-making and models these strategies with 2 simulated clinical patient visits. Common barriers, such as medication access and adherence, also are discussed, along with practical solutions for overcoming these care obstacles. 

Presenter:

Kathleen A. Lusk, PharmD, BCPS, BCCP
Associate Professor and Vice Chair
Department of Pharmacy Practice
University of the Incarnate Word Feik School of Pharmacy 
Adjunct Assistant Professor
Clinical Pharmacy Specialist
Division of Cardiology
Department of Medicine
UT Health San Antonio
San Antonio, Texas

Content is based on an online CE program supported by an educational grant from the Bristol Myers Squibb Pfizer Alliance.

This podcast series was first delivered as live webinars, which are now available as on-demand, CE-certified microlearning modules with downloadable slidesets. The program also features a ClinicalThought commentary and a downloadable infographic reference guide. To access the full program, go to:
https://bit.ly/3OMazV8

This podcast is the second in a series of three featuring insights from expert cardiology pharmacists on nonvalvular atrial fibrillation (NVAF). In this episode, cardiology pharmacist Stephanie Dwyer Kaluzna, PharmD, BCCP, reviews key literature and guideline recommendations for stroke prevention in patients with NVAF. Dr Dwyer Kaluzna discusses the most recent evidence for prescribing, dosing, and monitoring direct oral anticoagulants (DOACs); using the risk-screening tools HAS-BLED and CHA2DS2-VASc to design patient-specific pharmacotherapy plans; and the use of DOACs in special patient populations, including older patients, patients with end-stage renal disease, and patients with low or high body weights.

Presenter:

Stephanie Dwyer Kaluzna, PharmD, BCCP  
Clinical Assistant Professor
Department of Pharmacy Practice
University of Illinois Chicago College of Pharmacy
Cardiovascular Clinical Pharmacist
University of Illinois Hospital and Health Science System
Chicago, Illinois

Content is based on an online CE program supported by an educational grant from the Bristol Myers Squibb Pfizer Alliance.

This podcast series was first delivered as live webinars, which are now available as on-demand, CE-certified microlearning modules with downloadable slidesets. The program also features a ClinicalThought commentary and a downloadable infographic reference guide. To access the full program, go to
https://bit.ly/3OMazV8

This podcast is the first in a series of three featuring cardiology pharmacists Kathleen A. Lusk, PharmD, BCPS, BCCP, and Stephanie Dwyer Kaluzna, PharmD, BCCP. In this episode, Drs Lusk and Dwyer Kaluzna provide an overview of nonvalvular atrial fibrillation (NVAF), including prevalence, burden, and consequences of undiagnosed NVAF and the role of pharmacists in screening for the condition in various pharmacy settings.

Presenters:

Kathleen A. Lusk, PharmD, BCPS, BCCP  
Associate Professor and Vice Chair  
Department of Pharmacy Practice
University of the Incarnate Word Feik School of Pharmacy  
Adjunct Assistant Professor
Clinical Pharmacy Specialist
Division of Cardiology
Department of Medicine
UT Health San Antonio
San Antonio, Texas

Stephanie Dwyer Kaluzna, PharmD, BCCP  
Clinical Assistant Professor
Department of Pharmacy Practice
University of Illinois Chicago College of Pharmacy
Cardiovascular Clinical Pharmacist
University of Illinois Hospital and Health Science System
Chicago, Illinois

Content is based on an online CE program supported by an educational grant from the Bristol Myers Squibb Pfizer Alliance.

This podcast series was first delivered as live webinars, which are now available as on-demand, CE-certified microlearning modules with downloadable slidesets. The program also features a ClinicalThought commentary and a downloadable infographic reference guide. To access the full program, go to
https://bit.ly/3OMazV8

In this episode, pharmacists Megan Adelman, PharmD, BCPS, BCGP, CDCES, and Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA, provide an overview of obesity, including pathophysiology and the benefits of long-term weight loss, and discuss guideline recommendations for treatment, pharmacotherapy options including injectable agents, and overcoming barriers to care.

Presenters:

Megan Adelman, PharmD, BCPS, BCGP, CDCES
Family Medicine Clinical Specialist
Center for Family Medicine
Cleveland Clinic Akron General
Akron, Ohio

Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA
Professor
Department of Pharmacy Practice
College of Pharmacy-Glendale
Midwestern University
Glendale, Arizona

Content based on an online CE program supported by an educational grant from Novo Nordisk, Inc.

Link to full program:
https://bit.ly/3EAARVu

Faculty

Tyree H. Kiser, PharmD, FCCM, FCCP, BCCCP, BCPS
Professor, Department of Clinical Pharmacy
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Critical Care Pharmacy Specialist, Department of Pharmacy
University of Colorado Hospital
Aurora, Colorado

Charles E. “Kurt” Mahan, PharmD, PhC, FASHP, FCCP
Adjunct Associate Professor, Pharmacy
University of New Mexico Health Sciences Center
Albuquerque, New Mexico
  

Content based on a CE activity supported by an educational grant from Alexion, AstraZeneca Rare Disease.
  

Link to full activity: https://www.proce.com/Anticoagulation

1:08 - Take-home thoughts for R/R MM 
3:47 - Summary of BCMA-targeted CAR T-cell therapy; Use of novel agents for R/R MM
6:47 - Information on melphalan flufenamide; Combination approaches with selinexor in clinical practice
9:59 - Cost considerations for treatment options in R/R MM
12:25 - Administration considerations for subcutaneous daratumumab and venetoclax in R/R MM

Faculty

Kathryn Maples, PharmD, BCOP
Clinical Pharmacy Specialist, Multiple Myeloma
Winship Cancer Institute, Emory Healthcare
Atlanta, Georgia

Tim Peterson, PharmD, BCOP
Clinical Pharmacy Specialist – Multiple Myeloma
Memorial Sloan Kettering Cancer Center
New York, New York
 

Content based on a CE activity supported by educational grants from Karyopharm Therapeutics, Inc. and Oncopeptides, Inc.

Link to full activity: 
https://www.proce.com/RRMM

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:

• Updated CDC recommendations for one-time universal screening for HBV
• Addressing patient-, provider-, and system-level barriers to universal HBV screening
• Best practices for implementation of HDV screening

Presenters:

Douglas Dieterich, MD
Director, Institute for Liver Medicine

Professor of Medicine

Division of Liver Diseases

Mount Sinai School of Medicine

New York, New York

Camilla S. Graham, MD, MPH
Co-Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts

Robert Wong, MD, MS 
Clinical Associate Professor
Division of Gastroenterology and Hepatology
Stanford University School of Medicine
Palo Alto, California

Link to full program:
https://bit.ly/3TuqFHI

Link to the slides: 
https://bit.ly/4atS42z

In this podcast, Julie Ann Justo, PharmD, MS, FIDSA, BCPS, discusses treatment of carbapenem-resistant Enterobacterales (CRE) infections, including:

• Burden of CRE infections in the United States
• Mechanisms of resistance
• Changing epidemiology
• Use of rapid diagnostic tests
• IDSA guidance recommendations, including supporting data
• Approach to designing treatment regimens, including weighing patient- and infection-related factors

Faculty:

Julie Ann Justo, PharmD, MS, FIDSA, BCPS
Clinical Pharmacist Lead – Infectious Diseases
Inpatient Pharmacy
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire

Link to full program: 
https://bit.ly/41a8Mj0

Link to accompanying ClinicalThought commentary:
https://bit.ly/4865T57

Link to downloadable infographic: 
https://bit.ly/3t7NpT2

In this accredited podcast episode, Dr Christina Madison and Dr Mary Bridgeman provide practical strategies for implementing RSV vaccination into practice, including: 

• Educating older adults on RSV vaccines 
• Providing effective, evidence-based recommendations
• Shared decision-making 
• Identifying and addressing vaccine hesitancy 
• Proactive strategies in vaccinating for RSV 
• Predicting and overcoming barriers to RSV vaccination 

Presenters:

Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey

Christina M. Madison, PharmD, FCCP, AAHIVP
Clinical Pharmacist
Founder and CEO, The Public Health Pharmacist, PLLC
Adjunct Associate Professor of Pharmacy Practice
Roseman University of Health Sciences
College of Pharmacy
Henderson, Nevada

Other program activities: 

• Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist’s Role 
  https://bit.ly/49GUv1g

Link to CME: Claim Credit – 
https://bit.ly/3uoY7VH

[After selecting the “Continue to Post Test” button:]

To receive continuing education credit, submit your posttest answers no later than the expiration of this activity. Select the best answer to each question. When you have completed all the questions, press the "Continue" button at the bottom.

In this accredited podcast episode, Dr Christina Madison and Dr Mary Bridgeman discuss the latest practical strategies for preventing RSV infection in older adults, including: 

• Role of basic public health precautions
• Available and emerging vaccines
• Mechanisms of action, therapeutic targets, and pharmacology
• Efficacy and safety data
• FDA approval status and ACIP recommendations

Presenters:  
Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey

Christina M. Madison, PharmD, FCCP, AAHIVP  
Clinical Pharmacist
Founder and CEO, The Public Health Pharmacist, PLLC
Adjunct Associate Professor of Pharmacy Practice
Roseman University of Health Sciences
College of Pharmacy
Henderson, Nevada

Other program activities:  

• Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist’s Role 

In this accredited podcast episode, Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP, discusses the most important things for pharmacists across all settings to know about RSV infections in patients 60 years of age or older, including: 

• Incidence and prevalence of RSV in older adults, including hospitalization, mortality, epidemiology
• Seasonality
• Clinical manifestations
• Risk factors for severe outcomes
• Vulnerable groups and comorbidities

Presenter:

Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey

Other program activities: 

• Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist’s Role 
  https://bit.ly/49GUv1g

Link to CME: Claim Credit – https://bit.ly/47GtNnK
[After selecting the “Continue to Post Test” button:]

To receive continuing education credit, submit your posttest answers no later than the expiration of this activity. Select the best answer to each question. When you have completed all the questions, press the "Continue" button at the bottom.

In this episode, Sarah Hayward, PharmD, BCOP, and Amy Ly Indorf, PharmD, BCOP, discuss their experiences providing care for patients with advanced ovarian cancer, with topics including:

• PARP inhibitors as frontline maintenance therapy
• Patient education and counseling on PARP inhibitors
• Helping patients access newer therapies
• Experiences with mirvetuximab soravtansine
• Patient education and counseling on mirvetuximab soravtansine
• Treatment modalities on the horizon 

Presenters:

Sarah Hayward, PharmD, BCOP
Clinical Pharmacy Specialist,
Gynecologic Oncology
Stephenson Cancer Center at
OU Health
Oklahoma City, Oklahoma

Amy Ly Indorf, PharmD, BCOP
Clinical Assistant Professor
University of Washington 
School of Pharmacy
Clinical Oncology Pharmacist
UW Medicine
Fred Hutchinson Cancer Center
Seattle, Washington

Supported by educational grants from GSK and Novocure, Inc.

Link to full program:
https://bit.ly/44fUiOU

In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including:

• Current COVID-19 landscape
• Rapid antigen tests and PCR tests
• Risk stratification of patients who have a positive SARS-CoV-2 test
• Antiviral treatment (nirmatrelvir + ritonavir, remdesivir, and molnupiravir)
• Long COVID

Presenters:
Renslow Sherer, MD
Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois

Trinh P. Vu, PharmD, BCIDP
Clinical Pharmacy Specialist in Infectious Diseases
Department of Pharmaceutical Services
Emory University Hospital Midtown
Atlanta, Georgia

To download the slides: bit.ly/3oHKC09

To view the full online program: bit.ly/4201xcO

In this episode, pharmacists Kristi W. Kelley, PharmD, FCCP, BCPS, BCACP, CDCES, BC-ADM, and Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP, discuss the use of GLP-1 receptor agonists in patients with type 2 diabetes and provide answers to commonly asked questions. Listen to their conversation about the differences between short-acting vs long-acting agents; the benefits of use in combination with other medications, such as SGLT2 inhibitors, DPP-4 inhibitors, and metformin; their benefits in heart failure; and their role in the updated consensus statement from the American Diabetes Association/European Association for the Study of Diabetes. 

Presenters:

Kristi W. Kelley, PharmD, FCCP, BCPS, BCACP, CDCES, BC-ADM
Clinical Professor
Department of Pharmacy Practice
Auburn University Harrison College of Pharmacy
Clinical Pharmacist
Baptist Health Foundation Center for Medical and Surgical Care
Princeton Baptist Medical Center/Brookwood Baptist Health
Birmingham, Alabama

Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP
Professor
Department of Pharmacy Practice
Midwestern University
College of Pharmacy
Downers Grove, Illinois
Clinical Pharmacist
Advocate Medical Group
Chicago, Illinois

Content based on an online CE program supported by an educational grant from Novo Nordisk, Inc.

Link to full program: 
https://bit.ly/3Un1xQi

In this episode, Alexa Basilio, PharmD, BCOP and Jessica Davis, PharmD, BCOP, CPP discuss immune-related adverse events and toxicities among patients using immune checkpoint inhibitors. This overview will include discussion about: 

• How and when to monitor and treat mild vs severe immune-related toxicities
• The art of balancing and tapering low-dose and high-dose corticosteroids
• Differentiating between immune-related and chemotherapy- or targeted therapy–associated adverse events for optimal management approaches
• Involvement of multidisciplinary teams early during treatment to prevent immune-related adverse events
• Importance of educating patients, caregivers, and providers on immune-related toxicities

Presenters: 

Alexa Basilio, PharmD, BCOP
University of Florida College of Pharmacy 
Oncology Pharmacy Specialist 
McKesson, The US Oncology Network
Tampa, Florida 

Jessica Davis, PharmD, BCOP, CPP 
Levine Cancer Institute
Clinical Pharmacist Coordinator, Adult Hematology/Oncology
Atrium Health Levine Center
Charlotte, North Carolina 

Link to full program: 
https://bit.ly/3We4HJy

Listen in as Jonathan A. Bernstein, MD, and Ryan Haumschild, PharmD, MS, MBA, CPEL, discuss how to manage the multidisciplinary care of patients with systemic mastocytosis (SM) from both the allergy/immunology and pharmacy perspective, including:

• Strategies to better identify patients presenting with features of SM to facilitate timely diagnosis
• Current guideline-recommended treatment approaches
• Emerging data on new targeted agents for SM
• Pharmacist-led strategies to help patients achieve better outcomes (e.g., specialist referral, polypharmacy counseling, and anaphylaxis education)

Presenters
Jonathan A. Bernstein, MD
Professor of Medicine
Division of Rheumatology, Allergy and Immunology
Department of Internal Medicine
University of Cincinnati College of Medicine
Partner Advanced Allergy Services, LLC
Partner Bernstein Clinical Research Center, LLC
Cincinnati, Ohio

Ryan Haumschild, PharmD, MS, MBA, CPEL
Vice President of Pharmacy, Ambulatory
Emory Healthcare
Winship Cancer Institute
Atlanta, Georgia

Full link to program page:
https://bit.ly/3HcA8z2

In this podcast episode, Allison Butts, PharmD, BCOP, reviews how pharmacists can help in providing comprehensive patient-centric care for patients with HR+/HER2- MBC and preexisting comorbid conditions, including:

• Common comorbidities and complexities in managing patients with HR+/HER2- MBC
• Treatment landscape for patients with HR+/HER2- MBC
• Real-world studies in women with HR+/HER2- MBC
• Mitigation and management of drug interactions and multidisciplinary team coordination treatment selection
• Patient goals and coordinating with multidisciplinary team to maximize quality of life

Link to full program:
https://bit.ly/4jCQe38

In this episode, hear Allison Butts, PharmD, BCOP and Danielle Roman, PharmD, BCOP, share their insights on the best practices for incorporating antibody–drug conjugates (ADCs) into clinical practice including:

• An overview of ADC structure and mechanism of action
• A topline review of data supporting the current FDA-approved indications for ADCs targeting HER2 and TROP-2 across multiple tumor types
• An in-depth look at common and serious adverse events with each approved ADC along with an overview of management strategies

Editor’s note: On June 23, 2025, the FDA granted accelerated approval for a new indication for datopotamab deruxtecan, one of the antibody drug conjugates discussed in this podcast. Datopotamab deruxtecan is now also approved for adults with locally advanced or metastatic EGFR-mutated NSCLC who have received previous EGFR-targeted therapy and platinum-based chemotherapy. 

Program faculty:

Allison Butts, PharmD, BCOP
Pharmacist Manager, Oncology
Clinical Pharmacist, Breast Oncology
UK HealthCare
Markey Cancer Center
Lexington, Kentucky

Danielle Roman, PharmD, BCOP
Manager, Oncology Clinical Pharmacy Services
Allegheny Health Network
Pittsburgh, Pennsylvania

Program page:
https://bit.ly/4lr7cT6

In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including:

• The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection)
• Cough as the most significant symptom and burden
• Imaging bronchiectasis with classic and inflammatory findings
• Differentiating the causes of NCFBE to inform patient care

Presenters

Brett M. Elicker, MD
Professor of Clinical Radiology
Chief, Cardiothoracic Imaging Division
Department of Radiology & Biomedical Imaging
University of California, San Francisco
San Francisco, California

David E. Griffith, MD, ATSF, FACCP, FRSM
Professor of Medicine
Division of Mycobacterial and Respiratory Diseases
Department of Medicine
National Jewish Health
Denver, Colorado

Program page: 
https://bit.ly/4mZbYsm

In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging subcutaneous immunotherapy options for patients with cancer including:

• Basic mechanism of action and role of hyaluronidase in subcutaneous immunotherapy formulation and available dosing/schedules
• Available pharmacodynamics/pharmacokinetics, efficacy, and safety data for subcutaneous immunotherapy formulations
• Current and potential models for administration of subcutaneous immunotherapy in the inpatient setting and day-to-day considerations

Presenters:

Kelly Romo, PharmD, BCOP
Manager, Oncology Medical Drug Management and Customer Initiatives
Blue Cross Blue Shield Michigan
Detroit, Michigan

Shawna Kraft, PharmD, BCOP
Clinical Pharmacist, Specialist
Michigan Medicine, Rogel Cancer Center
Clinical Associate Professor
University of Michigan College of Pharmacy
Ann Arbor, Michigan

Resources:
Consolidate your learning with a recording from an on-demand webcast, download the slides associated with this discussion, or read an expert text module or commentary on this topic.